FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Informations projet

FibroFix

N° de convention de subvention: 854646

DOI

10.3030/854646

Projet clôturé

Date de signature de la CE 11 Avril 2019

Date de début 1 Janvier 2019

Date de fin 30 Avril 2019

Financé au titre de

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Coût total

€ 71 429,00

Contribution de l’UE

€ 50 000,00

Coordonné par

ORTHOX LIMITED
United Kingdom

Periodic Reporting for period 1 - FibroFix (FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.)

Période du rapport: 2019-01-01 au 2019-04-30

Résumé du contexte et des objectifs généraux du projet

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Orthox has developed and plans to bring to market FibroFix Cartilage - a product developed to treat damage to the articular cartilage in the knee, including degeneration and OA.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

During the feasibility assessment, Orthox has completed a full analysis of the technical and business potential of their FibroFix Cartilage. Throughout the project, Orthox has greatly expanded their knowledge regarding the clinical validation and regulatyory approval required for the European market launch. Orthox also identified all key stakeholders needed for commercialisation.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

To prevent total knee replacement, many patients who suffer injury to the meniscus or knee cartilage are advised to limit their activity or risk deterioration of the joint. Orthox offers an alternative - strong, resilient, natural implants capable of restoring knee function while allowing the body’s own cells to grow through and integrate with the device. It is expected that this solution will allow patients to return to a fully active, pain-free lifestyle.

silk-cocoon-orthox.jpg

fibrofix-cartilage-orthox.jpg